OBJECTIVES: Systemic lupus erythematosus (SLE) can result in comorbidities and high disease severity. The aim of this study was to evaluate the effects of age, sex, race, ethnicity, cost of hospitalization, length of stay, and payor source on SLE disease severity scores. DESIGN: Epidemiological study. SETTING: Hospital discharge data were obtained from the DFW Hospital Council (DFWHC), for 65,535 patients hospitalized in the North Texas Dallas-Fort Worth (DFW) Metropolitan Statistical Area (MSA) from 1999-2005 with at least one autoimmune disease. PATIENTS: Of the 65,535 autoimmune patients, 14,829 patients had SLE as a diagnosis. The sample was assessed for disease severity according to the SLE comorbidity Index. MAIN OUTCOME: Disease severity, SLE comorbidities. RESULTS: SLE patients were younger and more than five times more likely to have multiple autoimmune diseases. More than one third of Hispanic patients were on Medicaid or self-pay and more likely to have higher disease severity. Race (Caucasian), sex (female), and payor source (PPO/POS) predicted lower disease severity scores. SLE was predictive of eight of the fourteen SLE-CI diseases, with greatest effects observed for nephritis (OR = 3.30, P < .0001), chronic renal failure (OR = 3.36, P < .0001), pericarditis (OR = 3.2, P < .0001), and pleuritis (OR = 2.06, P < .0001). Non-Caucasian patients were more likely to have chronic renal failure, nephritis, congestive heart failure, pericarditis and pleuritis. CONCLUSIONS: The comorbidities that exist in SLE vary according to ethnicity. It is paramount for physicians to be cognizant of these disparities and make appropriate referrals.
OBJECTIVES:Systemic lupus erythematosus (SLE) can result in comorbidities and high disease severity. The aim of this study was to evaluate the effects of age, sex, race, ethnicity, cost of hospitalization, length of stay, and payor source on SLE disease severity scores. DESIGN: Epidemiological study. SETTING: Hospital discharge data were obtained from the DFW Hospital Council (DFWHC), for 65,535 patients hospitalized in the North Texas Dallas-Fort Worth (DFW) Metropolitan Statistical Area (MSA) from 1999-2005 with at least one autoimmune disease. PATIENTS: Of the 65,535 autoimmune patients, 14,829 patients had SLE as a diagnosis. The sample was assessed for disease severity according to the SLE comorbidity Index. MAIN OUTCOME: Disease severity, SLE comorbidities. RESULTS:SLEpatients were younger and more than five times more likely to have multiple autoimmune diseases. More than one third of Hispanic patients were on Medicaid or self-pay and more likely to have higher disease severity. Race (Caucasian), sex (female), and payor source (PPO/POS) predicted lower disease severity scores. SLE was predictive of eight of the fourteen SLE-CI diseases, with greatest effects observed for nephritis (OR = 3.30, P < .0001), chronic renal failure (OR = 3.36, P < .0001), pericarditis (OR = 3.2, P < .0001), and pleuritis (OR = 2.06, P < .0001). Non-Caucasian patients were more likely to have chronic renal failure, nephritis, congestive heart failure, pericarditis and pleuritis. CONCLUSIONS: The comorbidities that exist in SLE vary according to ethnicity. It is paramount for physicians to be cognizant of these disparities and make appropriate referrals.
Authors: Nathan E Wineinger; Nicholas M Pajewski; Richard E Kennedy; Mary K Wojczynski; Laura K Vaughan; Steven C Hunt; C Charles Gu; Dabeeru C Rao; Rachel Lorier; Ulrich Broeckel; Donna K Arnett; Hemant K Tiwari Journal: Eur J Hum Genet Date: 2011-06-15 Impact factor: 4.246
Authors: Theresa L Walunas; Kathryn L Jackson; Anh H Chung; Karen A Mancera-Cuevas; Daniel L Erickson; Rosalind Ramsey-Goldman; Abel Kho Journal: Arthritis Care Res (Hoboken) Date: 2017-08-08 Impact factor: 4.794
Authors: Ryan Webb; Jennifer A Kelly; Emily C Somers; Travis Hughes; Kenneth M Kaufman; Elena Sanchez; Swapan K Nath; Gail Bruner; Marta E Alarcón-Riquelme; Gary S Gilkeson; Diane L Kamen; Bruce C Richardson; John B Harley; Amr H Sawalha Journal: Ann Rheum Dis Date: 2010-09-29 Impact factor: 19.103
Authors: Briton Lee; Edward W Holt; Robert J Wong; Justin L Sewell; Ma Somsouk; Mandana Khalili; Jacquelyn J Maher; Michele M Tana Journal: Autoimmunity Date: 2018-06-11 Impact factor: 2.815
Authors: Hong Sang Choi; Kyung-Do Han; Jin-Hyung Jung; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim Journal: Medicine (Baltimore) Date: 2019-07 Impact factor: 1.817
Authors: Cristina Arriens; Roberta Vezza Alexander; Sonali Narain; Amit Saxena; Christopher E Collins; Daniel J Wallace; Elena Massarotti; John Conklin; Kenneth C Kalunian; Chaim Putterman; Rosalind Ramsey-Goldman; Jill P Buyon; Anca Askanase; Richard A Furie; Judith A James; Ghalib A Bello; Susan Manzi; Joseph Ahearn; Tyler O'Malley; Arthur Weinstein; Thierry Dervieux Journal: Lupus Sci Med Date: 2020-04